Fiche publication
Date publication
janvier 2017
Journal
Mediators of inflammation
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BATTAGLIA-HSU Shyue-Fang
Tous les auteurs :
Feigerlová E, Battaglia-Hsu SF
Lien Pubmed
Résumé
Monoclonal gammopathies (MG) are classically associated with lytic bone lesions, hypercalcemia, anemia, and renal insufficiency. However, in some cases, symptoms of endocrine dysfunction are more prominent than these classical signs and misdiagnosis can thus be possible. This concerns especially the situation where the presence of M-protein is limited and the serum protein electrophoresis (sPEP) appears normal. To understand the origin of the endocrine symptoms associated with MG, we overview here the current knowledge on the complexity of interactions between cytokines and the endocrine system in MG and discuss the perspectives for both the diagnosis and treatments for this class of diseases. We also illustrate the role of major cytokines and growth factors such as IL-6, IL-1, TNF-, and VEGF in the endocrine system, as these tumor-relevant signaling molecules not only help the clonal expansion and invasion of the tumor cells but also influence cellular metabolism through autocrine, paracrine, and endocrine mechanisms. We further discuss the broader impact of these tumor environment-derived molecules and proinflammatory state on systemic hormone signaling. The diagnostic challenges and clinical work-up are illustrated from the point of view of an endocrinologist.
Mots clés
Animals, Cytokines, metabolism, Endocrine System, metabolism, Humans, Interleukin-1beta, metabolism, Interleukin-6, metabolism, Neoplasms, Plasma Cell, Plasma Cells, metabolism, Tumor Necrosis Factor-alpha, metabolism, Vascular Endothelial Growth Factor A, metabolism
Référence
Mediators Inflamm.. 2017 ;2017:7586174
